A Nationwide Prospective Surveillance study assessing dynamics of Invasive Pneumococcal Disease in Israel in Children and Adults in the PCV13 Era
Latest Information Update: 31 Jul 2021
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- 31 Jul 2021 New trial record
- 22 Jul 2021 Results published in the Clinical Infectious Diseases